|
Avastin No Benefit to Older Lung Cancer Patients: Study
U.S. News & World Report By Steven Reinberg TUESDAY, April 17 (HealthDay News) — Medicare patients who have advanced non-small cell lung cancer appear to get no survival benefit from adding the drug Avastin to standard chemotherapy, researchers from the Dana-Farber Cancer … Avastin Fails to Help Older Lung-Cancer Patients in Study Adding Drug to Standard Chemotherapy Provides No Survival Benefit for Older … Study examines drug regimen for the treatment of non-small cell lung cancer … |
View full post on lung cancer – Google News
